Virtu Financial LLC Chemomab Therapeutics Ltd. Transaction History

Virtu Financial LLC

  • $1.43 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 26, 2024
BUY
$0.45 - $0.9 $11,613 - $23,227
25,808 New
25,808 $13,000
Q1 2022

May 17, 2022
SELL
$3.53 - $7.2 $79,216 - $161,575
-22,441 Closed
0 $0
Q4 2021

Feb 17, 2022
BUY
$6.41 - $11.13 $143,846 - $249,768
22,441 New
22,441 $155,000
Q3 2021

Nov 12, 2021
SELL
$11.08 - $19.17 $146,034 - $252,660
-13,180 Closed
0 $0
Q2 2021

Sep 17, 2021
BUY
$16.07 - $55.0 $211,802 - $724,900
13,180 New
13,180 $251,000

Others Institutions Holding CMMB

# of Institutions
17
Shares Held
2.68M
Call Options Held
0
Put Options Held
0
View Full List

About Chemomab Therapeutics Ltd.

CMMB Quotes by TradingView
  • Ticker CMMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,431,700
  • Market Cap $18.2M
  • Description
  • Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (...
More about CMMB
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email